BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32336600)

  • 1. Immune response to bovine viral diarrhea virus (BVDV) vaccines detecting antibodies to BVDV subtypes 1a, 1b, 2a, and 2c.
    Fulton RW; Cook BJ; Payton ME; Burge LJ; Step DL
    Vaccine; 2020 May; 38(24):4032-4037. PubMed ID: 32336600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of species and subgenotypes of bovine viral diarrhea virus on control by vaccination.
    Fulton RW
    Anim Health Res Rev; 2015 Jun; 16(1):40-54. PubMed ID: 26050571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of calves persistently infected with noncytopathic bovine viral diarrhea virus (BVDV) subtype 1b after vaccination with heterologous BVDV strains in modified live virus vaccines and Mannheimia haemolytica bacterin-toxoid.
    Fulton RW; Step DL; Ridpath JF; Saliki JT; Confer AW; Johnson BJ; Briggs RE; Hawley RV; Burge LJ; Payton ME
    Vaccine; 2003 Jun; 21(21-22):2980-5. PubMed ID: 12798641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of bovine viral diarrhea virus 1b to susceptible and vaccinated calves by exposure to persistently infected calves.
    Fulton RW; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Payton ME; Duff GC; Step DL; Walker DA
    Can J Vet Res; 2005 Jul; 69(3):161-9. PubMed ID: 16187545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine viral diarrhea virus (BVDV) 1b: predominant BVDV subtype in calves with respiratory disease.
    Fulton RW; Ridpath JF; Saliki JT; Briggs RE; Confer AW; Burge LJ; Purdy CW; Loan RW; Duff GC; Payton ME
    Can J Vet Res; 2002 Jul; 66(3):181-90. PubMed ID: 12146890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternally derived humoral immunity to bovine viral diarrhea virus (BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza-3 virus bovine respiratory syncytial virus, Mannheimia haemolytica and Pasteurella multocida in beef calves, antibody decline by half-life studies and effect on response to vaccination.
    Fulton RW; Briggs RE; Payton ME; Confer AW; Saliki JT; Ridpath JF; Burge LJ; Duff GC
    Vaccine; 2004 Jan; 22(5-6):643-9. PubMed ID: 14741155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programmes.
    Fulton RW; Ridpath JF; Confer AW; Saliki JT; Burge LJ; Payton ME
    Biologicals; 2003 Jun; 31(2):89-95. PubMed ID: 12770537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
    Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
    Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenge with Bovine viral diarrhea virus by exposure to persistently infected calves: protection by vaccination and negative results of antigen testing in nonvaccinated acutely infected calves.
    Fulton RW; Johnson BJ; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Burge LJ; Step DL; Walker DA; Payton ME
    Can J Vet Res; 2006 Apr; 70(2):121-7. PubMed ID: 16639944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical significance of heterogeneity among BVDV strains: impact of biotype and genotype on U.S. control programs.
    Ridpath JF
    Prev Vet Med; 2005 Nov; 72(1-2):17-30; discussion 215-9. PubMed ID: 16183156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine viral diarrhoea virus (BVDV) subgenotypes in diagnostic laboratory accessions: distribution of BVDV1a, 1b, and 2a subgenotypes.
    Fulton RW; Ridpath JF; Ore S; Confer AW; Saliki JT; Burge LJ; Payton ME
    Vet Microbiol; 2005 Nov; 111(1-2):35-40. PubMed ID: 16263224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune response and assessment of vaccine virus shedding in calves receiving modified live virus vaccines containing bovine herpesvirus-1 and bovine viral diarrhoea virus 1a.
    Fulton RW; Saliki JT; Burge LJ; Payton ME
    J Vet Med B Infect Dis Vet Public Health; 2003 Feb; 50(1):31-7. PubMed ID: 12710498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
    Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
    Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b.
    Leyh RD; Fulton RW; Stegner JE; Goodyear MD; Witte SB; Taylor LP; Johnson BJ; Step DL; Ridpath JF; Holland BP
    Am J Vet Res; 2011 Mar; 72(3):367-75. PubMed ID: 21355740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
    Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
    Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
    Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of persistently infected heifer calves with bovine viral diarrhea virus subgenotypes 1b and 1d in a BVDV-vaccinated open dairy herd.
    Fritzen JTT; Zucoloto NZ; Lorenzetti E; Alfieri AF; Alfieri AA
    Acta Trop; 2024 Jun; 254():107198. PubMed ID: 38531427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of reproductive performance of primiparous dairy cattle following revaccination with either modified-live or killed multivalent viral vaccines in early lactation.
    Walz PH; Montgomery T; Passler T; Riddell KP; Braden TD; Zhang Y; Galik PK; Zuidhof S
    J Dairy Sci; 2015 Dec; 98(12):8753-63. PubMed ID: 26454300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
    Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
    Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.